Effect of AAF-2-h1L-10 on immune response following toxic degeneration caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in micep.345

L Joniec, Andrzej Członkowski(Medical University of Warsaw), Piotr Hadaczek(University of California, San Francisco), Joanna Schwenkgrub(Centre National de la Recherche Scientifique), Agnieszka Ciesielska(Gladstone Institutes), Anna Członkowska(Institute of Psychiatry and Neurology), Agnieszka Cudna(Medical University of Warsaw), A Sznejder, K Bankiewicz, A. Gladka
Acta Neurobiologiae Experimentalis
January 1, 2009
Cited by 0

Related Papers

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
|The Lancet|2012|1.2k
Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial
|The Lancet Neurology|2018|178
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
|Neurology|2021|155
Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease
|Neurology|2005|122
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
|The Lancet Neurology|2023|95